M&T Bank
RLAY icon

M&T Bank’s Relay Therapeutics RLAY Stock Holding History

M&T Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-54,250
Closed -$451K – 1634
2024
Q1 		$451K Sell
54,250
-35
-0.1% -$341 ﹤0.01% 1175
2023
Q4 		$598K Buy
54,285
+8,272
+18% +$69.8K ﹤0.01% 1060
2023
Q3 		$387K Buy
46,013
+14,645
+47% +$157K ﹤0.01% 1183
2023
Q2 		$394K Buy
31,368
+3,974
+15% +$49.4K ﹤0.01% 1210
2023
Q1 		$452K Hold
27,394
– – ﹤0.01% 1150
2022
Q4 		$410K Buy
27,394
+4,194
+18% +$80.3K ﹤0.01% 1182
2022
Q3 		$518K Sell
23,200
-3,902
-14% -$85.6K ﹤0.01% 1073
2022
Q2 		$454K Buy
27,102
+16,586
+158% +$355K ﹤0.01% 1048
2022
Q1 		$315K Hold
10,516
– – ﹤0.01% 1177
2021
Q4 		$323K Buy
10,516
+2,727
+35% +$86.2K ﹤0.01% 1215
2021
Q3 		$246K Buy
7,789
+1,959
+34% +$65.9K ﹤0.01% 1342
2021
Q2 		$213K Hold
5,830
– – ﹤0.01% 1439
2021
Q1 		$202K Buy
5,830
+690
+13% +$29.9K ﹤0.01% 1423
2020
Q4 		$214K Hold
5,140
– – ﹤0.01% 1492
2020
Q3 		$219K Buy
+5,140
New +$196K ﹤0.01% 1381

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

M&T Bank's RLAY Position: Q2 2024 in Review

M&T Bank sold out of Relay Therapeutics (RLAY) in Q2 2024, closing a stake of 54,250 shares — an estimated $451K sold.

M&T Bank first reported a position in RLAY in Q3 2020 and held it in 15 quarters. The position peaked at $598K in Q4 2023. 178 funds tracked by Wall St. Rank hold RLAY as of Q2 2024.

  • M&T Bank reported no remaining Relay Therapeutics position as of Q2 2024 after selling out during the quarter.
  • M&T Bank sold 54,250 Relay Therapeutics shares in Q2 2024, an estimated $451K.
  • M&T Bank first reported a position in Relay Therapeutics in Q3 2020 and held it in 15 quarters.
  • M&T Bank's Relay Therapeutics position peaked at $598K in Q4 2023.
  • 178 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2024.

Based on M&T Bank's 13F filing for Q2 2024, filed 31 Jul 2024.